Skin abscess antibiotic therapy during pregnancy
Incision and drainage is the primary treatment for a skin abscess. [1] When an antibiotic is indicated for purulent infection in pregnancy, an agent with activity against community-associated MRSA is recommended. [1] Clindamycin is an appropriate empiric MRSA-active oral option in pregnancy. [2]
Medication selection algorithm
For a purulent skin abscess, antibiotic selection is based on MRSA risk and illness severity. [1]
- MRSA coverage indicated (purulent abscess where MRSA is a concern): clindamycin [2]
- MRSA coverage not required (low MRSA risk) and beta-lactam therapy used for typical staphylococcal pathogens: a beta-lactam active vs MSSA may be selected (exact agent selection is based on local susceptibility patterns). [1]
- Trimethoprim-sulfamethoxazole: generally avoided in the third trimester of pregnancy. [2]
- Doxycycline/tetracyclines: not recommended during pregnancy. [2]
Core recommendation
Oral antibiotic therapy should be added to incision and drainage when antibiotics are indicated for the abscess. [1] For patients in whom MRSA is suspected or confirmed, clindamycin or trimethoprim-sulfamethoxazole are recommended by IDSA guidance when MRSA coverage is needed. [1] In pregnancy, clindamycin is listed as an empiric MRSA option, while trimethoprim-sulfamethoxazole is not recommended in the third trimester. [2]
Monotherapy vs combination therapy
Monotherapy with a single MRSA-active agent is used for uncomplicated purulent skin abscesses when outpatient therapy is appropriate. [1] Combination therapy is not routinely required for purulent skin abscesses in guideline-directed outpatient management. [1]
Initiation thresholds and indications
Antibiotics should be initiated when the abscess is accompanied by systemic features or when there are other clinical factors suggesting complicated infection rather than incision and drainage alone. [1] For severe illness or inability to tolerate oral therapy, inpatient management is indicated. [1]
Key evidence supporting this recommendation
IDSA guidance supports adjunctive antibiotics (with MRSA activity) for abscesses when indicated, because many cases of purulent SSTI improve with incision and drainage plus targeted therapy rather than beta-lactam-only strategies. [1]
Common pitfalls to avoid
Tetracyclines (including doxycycline) should not be used during pregnancy. [2] Trimethoprim-sulfamethoxazole should not be used in the third trimester of pregnancy. [2] Beta-lactam-only empiric therapy without MRSA coverage should be avoided when MRSA is a clinically relevant consideration for a purulent abscess. [1]
Target goals of therapy
Therapy goals are clinical improvement of purulence and surrounding infection after incision and drainage. [1] Therapy should provide appropriate coverage for suspected community-associated MRSA when indicated. [1]